Frailty syndrome in the elderly
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. over 65 years old; 2. Meet the following criteria: a. self-care or basic self-care; b. Basically normal cognitive function; 3. agree to participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Major cardiovascular and cerebrovascular events (including myocardial infarction, angina, and stroke) occurred in the past 3 months Middle and arterial revascularization); 2. patients with heart failure and lower cardiac function than class II; 3. patients with malignant tumors; 4. inability to cooperate with treatment and follow-up; 5. participating in other clinical trials; 6. patients who could not tolerate the study drug or used the intervention drug within 3 months; 7. Participants who were considered not to be included by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 6; | — |
Secondary
| Measure | Time frame |
|---|---|
| Aging damage markers (8-oxoGsn, SIRT1, SIRT3);Aging-regulated growth factors(IGF-1,FGF21,GDF15,GDF5,GDF8/MSTN);Inflammatory cytokines(TNF-a,CRP,IL-6);Hormone-related indicators(leptin,Cortisol, Dehydroepiandrosterone (DHEA));Routine inspection(Routine blood test, blood biochemical indexes);Fecal metagenomic testing; | — |
Countries
China
Contacts
The First Affiliated Hospital of PLA Air Force Medical University